Speaker Details

Jennifer Lin Hsiao, MD, FAAD

Jennifer Lin Hsiao, MD, FAAD

SESSIONS

P004 A New Paradigm in the Management of the Hidradenitis Suppurativa Disease Spectrum
Jul 17, 2026 • 1:00 PM - 3:00 PM • Trianon Ballroom
P007 Hidradenitis Suppurativa: Case-Based Clinical Pearls
Jul 18, 2026 • 8:45 AM - 10:45 AM • Sutton North

DISCLOSURES

AbbVie – Consultant(Fees), Speaker(Fees); Aclaris Therapeutics Inc. – Consultant (1099 relationship)(Fees); Amgen – Investigator(Grants/Research Funding); Astra Zeneca – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Fees); Galderma – Speaker(Fees); Incyte – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Insmed – Consultant (1099 relationship)(Fees); Leo Pharma – Consultant (1099 relationship)(Fees); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Fees); Navigator Medicines – Consultant (1099 relationship)(Fees); Novartis – Consultant(Fees), Speaker(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees); Sanofi – Consultant (1099 relationship)(Fees); Sanofi/Regeneron – Speaker(Fees); UCB – Consultant(Fees), Speaker(Fees);